These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18171544)

  • 1. [Correlation between GP73 protein and human liver disease].
    Tan LY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):958-9. PubMed ID: 18171544
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
    Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease- and cell-specific expression of GP73 in human liver disease.
    Iftikhar R; Kladney RD; Havlioglu N; Schmitt-Gräff A; Gusmirovic I; Solomon H; Luxon BA; Bacon BR; Fimmel CJ
    Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP73 and liver disease: a (Golgi) complex enigma.
    Maitra A; Thuluvath PJ
    Am J Gastroenterol; 2004 Jun; 99(6):1096-8. PubMed ID: 15180731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases.
    Gu Y; Chen W; Zhao Y; Chen L; Peng T
    Ann Clin Biochem; 2009 Jan; 46(Pt 1):38-43. PubMed ID: 19008260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
    J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantification of serum antibodies against liver cell membrane (anti-LM) in patients with liver diseases by ELISA--fixation of the antibody on a microplate using protein A and the significance of anti-LM detection].
    Tsuji T
    Rinsho Byori; 1983 Jun; 31(6):641-5. PubMed ID: 6361333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current status of the theories of the chronicity of liver diseases].
    Damianov B
    Vutr Boles; 1981; 20(2):25-32. PubMed ID: 7020250
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of antibodies to Chang liver cell in sera from patients with chronic liver diseases by 125I-labelled protein A binding assay and the effect of prednisolone and 6-mercaptopurine treatment on the level of the antibodies.
    Inagaki Y; Morizane T; Matsumura S; Kawamura N; Watanabe T; Kumagai N; Nakamura T; Tsuchimoto K; Tsuchiya M
    Clin Exp Immunol; 1984 Jul; 57(1):79-84. PubMed ID: 6540149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of liver membrane autoantibodies detected with rat liver section and Chang liver cells].
    Sugiura M; Tomiyama H; Tsukada M; Shizawa M; Maruyama S; Ishido T; Hino K; Yoshiwara N
    Rinsho Byori; 1986 Mar; 34(3):319-24. PubMed ID: 3712793
    [No Abstract]   [Full Text] [Related]  

  • 13. Polycystic liver and kidney diseases.
    Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
    Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development and a clinical trial of an erythrocytic diagnostic agent for determining antibodies to the liver-specific lipoprotein].
    Zhavoronok SV; Semenov VM; Chertoritskaia ML; Kalinin AL
    Lab Delo; 1989; (8):56-60. PubMed ID: 2477633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Markers of the hepatitis B virus in the blood serum and liver tissue in chronic diffuse diseases].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI; Asfandiiarova NS
    Arkh Patol; 1989; 51(8):40-5. PubMed ID: 2818226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoaffinity purification and characterization of a human liver-specific antigen.
    Seo Y; Nakayama T; Takahama K
    Nihon Hoigaku Zasshi; 1993 Feb; 47(1):1-5. PubMed ID: 8315854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.
    Feighery C; McDonald GS; Greally JF; Weir DG
    Clin Exp Immunol; 1981 Jul; 45(1):143-51. PubMed ID: 7307345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.
    Uibo RM; Helin HJ; Krohn KJ
    Clin Exp Immunol; 1982 May; 48(2):505-12. PubMed ID: 7105494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic liver disease is a disorder of cotranslational protein processing.
    Drenth JP; Martina JA; van de Kerkhof R; Bonifacino JS; Jansen JB
    Trends Mol Med; 2005 Jan; 11(1):37-42. PubMed ID: 15649821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.